Skip to content
HCC Buddy home

F13.980 ICD-10-CM Code: Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder

F13.980 maps to CMS-HCC V28 137. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupF13.980

FY 2026 Apr update / Mental, Behavioral and Neurodevelopmental disorders (F01-F99) / Mental and behavioral disorders due to psychoactive substance use (F10-F19)

F13.980

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder

A person uses sedative, hypnotic, or anti-anxiety medications without a diagnosed substance use disorder and develops anxiety as a result of using these drugs.

Buddy the Bee presenting code insight

Buddy Insight

Unspecified sedative use with induced anxiety disorder indicates anxiety symptoms caused by sedative use where the use pattern has not been classified.

OverviewRisk ModelsCode BookDocumentationAuditNotesEdition comparison

CMS-HCC V28

HCC 137

Coefficient HCC 137: 0.424 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 082

Code-level coefficient reference

ESRD/PACE

HCC 55

Code-level coefficient reference

RXHCC

N/A

—

Not mapped

Code Book Path

Official
F13.9Sedative, hypnotic or anxiolytic-related use, unspecifiedF13.98Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disordersF13.980Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder

Inclusion Terms

Official
  • Sedative, hypnotic, or anxiolytic-induced anxiety disorder, without use disorder

Excludes 2

Official
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)Inherited from F01-F99

Related Codes

Official
F13.981Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunctionF13.982Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorderF13.988Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder

Includes

Official
  • disorders of psychological developmentInherited from F01-F99

Excludes 1

Official
  • sedative, hypnotic or anxiolytic-related abuse (F13.1-)Inherited from F13.9
  • sedative, hypnotic or anxiolytic-related dependence (F13.2-)Inherited from F13.9

Code First

Official

No Code First sequencing instructions are included in this display for F13.980. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for F13.980. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for F13.980. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Documentation of sedative, hypnotic, or anxiolytic use
Description of anxiety symptoms attributed to the substance
Temporal relationship between substance use and anxiety onset
Clinical distinction from pre-existing primary anxiety disorders

MEAT Support

HCC Buddy guidance
Documentation of sedative, hypnotic, or anxiolytic use
Description of anxiety symptoms attributed to the substance
Temporal relationship between substance use and anxiety onset
Clinical distinction from pre-existing primary anxiety disorders

Audit Caution

HCC Buddy guidance
Coding primary anxiety disorder when the anxiety is substance-induced
Confusing withdrawal anxiety with induced anxiety disorder — different mechanisms
Not attempting to determine the use pattern (abuse vs dependence)
Missing the paradoxical nature of anxiolytic-induced anxiety

Common Mistakes

HCC Buddy guidance
F13.180 — Sedative ABUSE with induced anxiety; when abuse is confirmed
F13.280 — Sedative DEPENDENCE with induced anxiety; when dependence is confirmed
F41.1 — Generalized anxiety disorder; primary anxiety, not substance-induced
F13.930 — Unspecified use with withdrawal uncomplicated; withdrawal anxiety differs from induced anxiety

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is F13.980 an HCC code?

Yes. F13.980 (Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder) maps to HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.424. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: F13.980 is billable and maps to V28 HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
F13.980
Description
Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
HCC (V28)
HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
RAF reference coefficient
0.424
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
0.424
ESRDHCC 55, Substance Use Disorder/Moderate/Severe/Substance Use with Complications
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work F13.980 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for F13.980

For F13.980, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

F13.980 is the ICD-10-CM diagnosis code for sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder. A person uses sedative, hypnotic, or anti-anxiety medications without a diagnosed substance use disorder and develops anxiety as a result of using these drugs. F13.980 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F13.980 maps to Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications (HCC 137) with a source-labeled community, non-dual, aged reference coefficient of 0.424. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

This code indicates unspecified use pattern (not abuse or dependence) with a specific induced condition; verify documentation doesn't indicate abuse or dependence which would require different codes. For F13.980, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for F13.980 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • •This code indicates unspecified use pattern (not abuse or dependence) with a specific induced condition; verify documentation doesn't indicate abuse or dependence which would require different codes
  • •Ensure the anxiety disorder is documented as directly induced by the sedative/hypnotic/anxiolytic use rather than a pre-existing condition

Clinical Significance

Unspecified sedative use with induced anxiety disorder indicates anxiety symptoms caused by sedative use where the use pattern has not been classified. This paradoxical complication is well-recognized with benzodiazepine use. The unspecified use status reflects incomplete documentation of the substance use pattern, which should be clarified when possible.

Documentation Requirements

  • ✓Documentation of sedative, hypnotic, or anxiolytic use
  • ✓Description of anxiety symptoms attributed to the substance
  • ✓Temporal relationship between substance use and anxiety onset
  • ✓Clinical distinction from pre-existing primary anxiety disorders
  • ✓Differentiation from withdrawal anxiety
  • ✓Assessment of anxiety severity

Commonly Confused Codes

  • •F13.180: Sedative ABUSE with induced anxiety; when abuse is confirmed
  • •F13.280: Sedative DEPENDENCE with induced anxiety; when dependence is confirmed
  • •F41.1: Generalized anxiety disorder; primary anxiety, not substance-induced
  • •F13.930: Unspecified use with withdrawal uncomplicated; withdrawal anxiety differs from induced anxiety
  • •F13.94: Unspecified use with induced mood disorder; different type of induced condition

Child Codes

F13.980Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
HCC 137
F13.981Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction
HCC 137
F13.982Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
HCC 137
F13.988Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder
HCC 137

Code Hierarchy

└F13Sedative, hypnotic, or anxiolytic related disorders└F13.9Sedative, hypnotic or anxiolytic-related use, unspecified└F13.98Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders└F13.980Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
└F13.980Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder

Also searched as

  • F13 980
  • F13980

For F13.980, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

F13.980 maps to CMS-HCC V28 category 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for F13.980. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work F13.980 in HCC Buddy

Open F13.980 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.

Open in Code BookOpen in EncoderStart Pro